Pathways' Pick of the Week: Africa Centralizes Medtech Regulations

article image
ARTICLE SUMMARY:

The African Medicines Agency launches. Excerpted from Pathways’ Picks May 28: Global Picks, FDA Guidance Docs, MDUFA Support, and More.

Africa is on the cusp of fully launching its continent-wide agency for centralizing and harmonizing oversight of drugs, vaccines, and medical devices. Even as the top-down structure of the African Medicines Agency (AMA) is still being put into place, there is already an infrastructure established to initiate medtech regulatory efforts. This foundation helped keep track of availability and performance of IVDs for COVID-19, and now it is stepping up to serve a more direct premarket review function for the continent in response to the Mpox (or monkeypox) outbreak in a growing number of African countries. (For more on AMA and medtech harmonization efforts in Africa, see in Market Pathways, Charting a Continent’s Course: Africa’s Push Toward Harmonized Medical Device Regulation.”)

Continue reading Pathways’ Picks here.
×



Articles from David Filmore:

Regulatory & Reimbursement

FDA Applies AI, CMS Seeks Tech Input, Korea Guides on Digital Health, and More

In this week’s Pathways Picks: FDA pursues aggressive plan to adopt AI tools to streamline reviews; the agency outlines its deregulation plan; CMS requests input on digital health apps for Medicare; medtech reimbursement bills resurface; South Korea and Hong Kong device guides; Brazil consultation; AI Act grandfathering; tariff testimony; and more.

Read Article